Apyx Medical Corp Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31)
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Apyx Medical Corp development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for the quarter ending 2015-09-30 was $0.00.
- Apyx Medical Corp development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for the quarter ending 2015-06-30 was $0.00.
- Apyx Medical Corp development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for the quarter ending 2015-03-31 was $11.53M.
| Period end | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 3 month | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 12 month |
|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | |
| 2015-03-31 | $11.53M 10-Q · filed 2015-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |